spacer
spacer

PDBsum entry 3swo

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Oxidoreductase PDB id
3swo

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
388 a.a.
Ligands
FDA ×4
EDO ×10
UNX ×15
Waters ×2097
PDB id:
3swo
Name: Oxidoreductase
Title: Crystal structure of a glutaryl-coa dehydrogenase from mycobacterium smegmatis in complex with fadh2
Structure: Glutaryl-coa dehydrogenase. Chain: a, b, c, d. Engineered: yes
Source: Mycobacterium smegmatis. Organism_taxid: 246196. Strain: atcc 7000084 / mc(2)155. Gene: msmeg_6686. Expressed in: escherichia coli. Expression_system_taxid: 469008.
Resolution:
1.45Å     R-factor:   0.128     R-free:   0.150
Authors: Seattle Structural Genomics Center For Infectious Disease (Ssgcid)
Key ref: L.Baugh et al. (2015). Increasing the structural coverage of tuberculosis drug targets. Tuberculosis (edinb), 95, 142-148. PubMed id: 25613812 DOI: 10.1016/j.tube.2014.12.003
Date:
14-Jul-11     Release date:   03-Aug-11    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
A0R6V6  (A0R6V6_MYCS2) -  Glutaryl-CoA dehydrogenase from Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155)
Seq:
Struc:
397 a.a.
388 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.1.3.8.6  - glutaryl-CoA dehydrogenase (ETF).
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: glutaryl-CoA + oxidized [electron-transfer flavoprotein] + 2 H+ = (2E)- butenoyl-CoA + reduced [electron-transfer flavoprotein] + CO2
glutaryl-CoA
+ oxidized [electron-transfer flavoprotein]
+ 2 × H(+)
= (2E)- butenoyl-CoA
+ reduced [electron-transfer flavoprotein]
Bound ligand (Het Group name = EDO)
matches with 40.00% similarity
+ CO2
      Cofactor: FAD
FAD
Bound ligand (Het Group name = FDA) corresponds exactly
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1016/j.tube.2014.12.003 Tuberculosis (edinb) 95:142-148 (2015)
PubMed id: 25613812  
 
 
Increasing the structural coverage of tuberculosis drug targets.
L.Baugh, I.Phan, D.W.Begley, M.C.Clifton, B.Armour, D.M.Dranow, B.M.Taylor, M.M.Muruthi, J.Abendroth, J.W.Fairman, D.Fox, S.H.Dieterich, B.L.Staker, A.S.Gardberg, R.Choi, S.N.Hewitt, A.J.Napuli, J.Myers, L.K.Barrett, Y.Zhang, M.Ferrell, E.Mundt, K.Thompkins, N.Tran, S.Lyons-Abbott, A.Abramov, A.Sekar, D.Serbzhinskiy, D.Lorimer, G.W.Buchko, R.Stacy, L.J.Stewart, T.E.Edwards, W.C.Van Voorhis, P.J.Myler.
 
  ABSTRACT  
 
No abstract given.

 

 

spacer

spacer